Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank49
3Y CAGR-4.2%
5Y CAGR-8.4%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-4.2%/yr
vs -18.4%/yr prior
5Y CAGR
-8.4%/yr
Recent acceleration
Acceleration
+14.2pp
Accelerating
Percentile
P49
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.09% |
| Q3 2025 | 2.77% |
| Q2 2025 | 3.95% |
| Q1 2025 | -0.69% |
| Q4 2024 | 3.12% |
| Q3 2024 | 4.61% |
| Q2 2024 | 4.10% |
| Q1 2024 | -1.14% |
| Q4 2023 | 3.63% |
| Q3 2023 | 4.00% |
| Q2 2023 | 5.33% |
| Q1 2023 | 6.04% |
| Q4 2022 | 2.37% |
| Q3 2022 | 0.11% |
| Q2 2022 | -3.87% |
| Q1 2022 | -7.19% |
| Q4 2021 | 1.92% |
| Q3 2021 | 4.69% |
| Q2 2021 | 2.49% |
| Q1 2021 | -0.14% |
| Q4 2020 | 3.23% |
| Q3 2020 | 3.34% |
| Q2 2020 | 5.28% |
| Q1 2020 | -3.37% |
| Q4 2019 | 1.24% |
| Q3 2019 | 4.58% |
| Q2 2019 | 4.53% |
| Q1 2019 | 1.31% |
| Q4 2018 | 1.33% |
| Q3 2018 | 1.37% |
| Q2 2018 | -3.53% |
| Q1 2018 | -2.22% |
| Q4 2017 | 2.73% |
| Q3 2017 | 2.32% |
| Q2 2017 | 3.59% |
| Q1 2017 | -1.30% |
| Q4 2016 | 0.33% |
| Q3 2016 | 1.64% |
| Q2 2016 | -1.03% |
| Q1 2016 | -1.16% |